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Abstract
Everyday functioning (EF) impairment is frequent in people living with HIV (PLWH). Our aim was to better explore EF and its
association with PLWH cognition, by administering both the IADL scale, the most common functional scale, and a new and
ecologic multi-domain (communication and financial skills) tool to measure EF as the University of California San Diego
(UCSD) Performance-Based Skills Assessment-Brief Version (UPSA-B). Eighty-five PLWH on cART with very good immu-
nological condition and 23 age- and education-matched healthy controls (HC) were enrolled. PLWH underwent a standardized
neuropsychological battery plus IADL, and cognitive impairment was defined according to Frascati criteria. Both groups
underwent the UPSA-B. Only 6 subjects (7%) were affected by cognitive impairment (asymptomatic profile). While IADL
score was at ceiling for all patients, the UPSA-B total score was significantly worse in PLWH when compared with HC [mean
82.1 (SD 9.3) vs 89.2 (SD 6.2); p < 0.001]. At communication subtest, PLWH group and HC were significantly different (p =
0.002), while no difference emerged at financial skills (p = 0.096). Higher score at UPSA-B was independently associated with
better global cognitive performance (composite Z-score) (β 7.79; p < 0.001). Also considering each single cognitive domain,
UPSA-B performance (both total and at subtests) confirmed the association with neurocognitive performance. In conclusion,
UPSA-B seems to better discriminate EF impairment than IADL in PLWH, and it was associatedwith cognitive functions, also in
the absence of symptomatic cognitive impairment. Thus, it appears a promising tool in the context of HIV infection to avoid
misdiagnosis and to better detect also mild EF.
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Introduction
HIV is a chronic illness, frequently resulting in everyday func-
tioning (EF) impairment. It is estimated that nearly 60% of
people living with HIV (PLWH) infection have problemswith
EF (Blackstone et al. 2013). EF impairment may affect basic
daily activities as cooking and housekeeping (Heaton et al.
2004), driving (Marcotte et al. 1999), and job efficiency
(Blackstone et al. 2013; Gorman et al. 2009; Heaton et al.
2004; Scott et al. 2011). The functional damage in everyday
life is a notable public health concern, since it is associated to
reduce ability to care for oneself and properly manage HIV
disease (Scott et al. 2011; Thames et al. 2011).
EF impairments among PLWH may be due to a combina-
tion of several factors, and it is still not well understood be-
cause of its factorial nature. Some predictors of EF impairment
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are lower cognitive reserve, neuropsychiatric complications,
mood, inadequate motivation, substance abuse, and advanced
HIV disease (Blackstone et al. 2013; Heaton et al. 2004;
Kamat et al. 2012; Milanini et al. 2016a, 2016b; Sadek et al.
2007). Among others, neurocognitive impairment is a strong
and substantial predictor of EF deficits in HIV disease, mainly
when involving executive functions, learning, attention, work-
ing memory, and linguistic abilities (Heaton et al. 2004).
The introduction of combined antiretroviral therapy
(cART) has produced a reduction in the overall incidence of
central nervous system (CNS) pathologies and of the most
severe forms of HIV-associated neurocognitive disorders
(HAND). However, prevalence of HAND is still approxi-
mately 25–50% because of milder forms persistence that still
affect PLWH despite the antiretroviral therapy (Ciccarelli
et al. 2013; Ciccarelli et al. 2019; Fabbiani et al. 2015;
Fabbiani et al. 2019; Heaton et al. 2011; Milanini et al.
2016a, 2016b; Sacktor et al. 2016; Simioni et al. 2010).
The current diagnostic categories of HAND, named
“Frascati criteria,” recognize three conditions: asymptomatic
neurocognitive impairment (ANI), mild neurocognitive disor-
der (MND), and HIV-associated dementia (HAD) (Antinori
et al. 2007; Heaton et al. 2010); the discrimination between
the first two patterns depends on functional impairment that
must be absent for ANI. Currently, the ANI profile is the most
represented in PLWH affected by HAND, especially in those
with suppressed plasma viral load (50% of HAND cases,
Robertson et al. 2007). Indeed, on the basis of Frascati criteria
classification, EF has a central role for the diagnostic differ-
entiation between HAND subcategories (Antinori et al. 2007).
Many tools have been proposed for the assessment of EF
impairment in PLWH, each of these showing some limita-
tions. Usually, EF is measured by IADL scale (Instrumental
Activities of Daily Living, Lawton and Brody 1969), but this
tool has shown low sensitivity in patients with no overt de-
mentia, and, as a self-reported questionnaire, it is sensitive to
errors due to retrospective recall, cognitive deficits, state-
dependent biases (e.g., depressed mood), affective distress,
and level of insight (Heaton et al. 2004). Furthermore, self-
reported attributions may be closely related to poor metacog-
nition, often affected by HAND (Casaletto et al. 2014; Juengst
et al. 2012), even in case of MND and ANI (Chiao and
Blizinsky 2013). Considering these limitations, MND is likely
underrated, and a misdiagnosis of asymptomatic HAND could
result in delayed interventions, more rapid disease progres-
sion, imprecise clinical recommendations, and an increased
risk of public health concerns (Obermeit et al. 2017).
Previous studies have highlighted the importance to use an
ecologic and multi-domain EF assessment, by adding a
performance-based evaluation to the common self-report
scales, in order to better differentiate asymptomatic versus
symptomatic HAND (Blackstone et al. 2012). In this regard,
many American studies had evaluated clinical utility of the
University of San Diego (UCSD) Performance-Based Skills
Assessment-Brief Version (UPSA-B) in PLWH.
UPSA-B is the short version of a performance-based as-
sessment used to measure functional capacity that expends
10 min and assesses financial and communication skills
through 4 tasks: counting money and making change, paying
bills, telephone use, and a medical appointment rescheduling
task. It was originally developed and validated in samples of
individuals with serious mental illness, showing sensitivity in
detecting psychiatric disorders and resulting associated with
employment status, residential independence, daily living
skills, and work skills (Mausbach et al. 2007; Patterson et al.
2001).
Afterwards it was noticed that also patients with
“amnestic” mild cognitive impairment performed significant-
ly worse than a cognitively healthy group on the UPSA that
showed a good sensitivity in detecting minor functional dam-
age (Goldberg et al. 2010). However, literature still reports
inconsistent results in PLWH. In particular, on one hand,
UPSA-B was able to differentiate PLWH with HAND from
PLWH without HAND (Moore et al. 2017; Sheppard et al.
2018), but on the other hand, it was relatively ineffective to
distinguish PLWH from healthy controls when authors con-
trolled for group differences in sex and education (Moore et al.
2017); moreover, the sensitivity and specificity values and the
cutoff scores differed across studies, and no associations with
manifest functioning variables (e.g., employment status,
IADL dependence) or quality of life in PLWH have been
found.
Thus, additional studies are needed to consolidate sensitiv-
ity of UPSA-B in detecting PLWH affected by milder forms
of cognitive and EF impairment. Our aimwas to better explore
EF and its association with cognitive functioning in an Italian




PLWH were consecutively enrolled from October 2018 to
June 2019 during routine outpatient visits at Infectious
Diseases Institute of “Policlinico Gemelli Foundation” of
Rome. Twenty-three age- and education-matched healthy
control (HC) were also enrolled.
Exclusion criteria in patients’ selection were as follows:
age < 18 years, active/past CNS opportunistic infections, his-
tory of neurological disorders, active psychiatric disorders,
alcoholism or drug abuse, and difficulties with the Italian
language.
Data on the following demographic, clinical, and laborato-
ry variables were collected for each participant at the time of
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neuropsychological testing: sex, age, education, ethnicity, risk
factors for HIV infection, time from HIV diagnosis, current
and past antiretroviral regimen, current and nadir CD4 cell
count, HIV-1 viral load, co-infection with hepatitis C virus
(HCV), comorbidities, and concomitant medications.
HC had no history or risk factors for neurologic impairment
and were not taking any medication deemed to affect cogni-
tive abilities. Theywere recruited among hospital personnel or
patients’ caregivers or relatives. All subjects were volunteers.
They did not receive any financial remuneration for
participating.
The study was approved by the institutional ethic commit-
tee and all participants provided written informed consent pri-
or to enrollment.
EF measures
To measure EF, IADL scale was administered; moreover,
both groups underwent UPSA-B assessing financial and com-
munication skills.
& IADL questionnaire (Instrumental Activities of Daily
Living) (Lawton and Brody 1969): a self-report measure
that asks participants to answer questions relating to the
level of assistance needed in managing finances, transpor-
tation, using the telephone, cooking, housekeeping and
laundry, buying groceries, and responsibility for own
medication.
& UCSD Performance-Based Skills Assessment-Brief
Version (UPSA-B) (Mausbach et al. 2007): a measure of
functional capacity (on a 0–100 scale where higher scores
correspond to better EF) in which subjects are asked to
role-play tasks in 2 areas of functioning: financial skills
and communication skills, which are assessed indepen-
dently. In the financial skills module, participants were
asked to count change, generate change from an item pur-
chased at a store, and pay a utility bill. In the communica-
tion skills module, participants were asked to dial a tele-
phone to contact emergency services, call information in
order to obtain a telephone number, and call a doctor in
order to reschedule an appointment.
Neuropsychological examination
PLWH underwent a standardized neuropsychological test bat-
tery (SNB), exploring memory, attention, language, executive
functions, and fine motor abilities. Cognitive areas were in-
vestigated as follows:
& Learning memory: the Rey Auditory Verbal Learning
Test (RAVLT)
& Attention: WAIS Digit Span, WAIS Digit Symbol
& Verbal fluency: FAS Test (subtest of the Neurosensory
Center Comprehensive Examination for Aphasia-
NCCEA)
& Executive functioning: multiple features target cancelation
(MFTC)
& Fine motor skills: Grooved Pegboard Test
Global performance was measured by transforming raw
scores at each task into standardized Z-scores using means
and standard deviations of Italian normative data (Capitani
and Laiacona 1997; Carlesimo et al. 1996) and averaging to
calculate a composite total and for each domain score.
Domain-specific impairment was defined as a Z-score less
than or equal to − 1. According to Frascati criteria (Antinori
et al. 2007), patients were considered affected by cognitive
disease if they showed impairment in at least two domains.
The profiles of ANI, MND, and HAD were differentiated on
the basis of the degree of cognitive and EF impairment (IADL
score).
Each patient was also submitted to the following
assessments:
& SF-36 (36-item Short-Form Health Survey) (Ware et al.
1993) investigating health-related quality of life, which
consists of 2 summary scores: physical health (physical
functioning, physical role limitations, bodily pain, general
health) and mental health (emotional role limitations, en-
ergy/fatigue, social functioning, emotional well-being).
Each area ranges from 0 to 100 (mean 50, SD 10), and
higher scores correspond to better health status. Elevated
negative perception of both mental and physical health
was considered if patient scored at least 1 SD below the
normative mean.
& Zung Self-Rating Depression Scale (Zung 1965; Zung
1986): a short self-report questionnaire which survey four
common characteristics of depression: the pervasive ef-
fect, the physiological equivalents, other disturbances,
and psychomotor activities. A score ≥ 50 is considered
corresponding to probable depression.
& Adherence to therapy questionnaire: a self-report judg-
ment about accuracy in taking antiretroviral drugs on a
0–100 Visual Analogue Scale (VAS) (Murri et al. 2010).
HC underwent a Mini Mental State Examination (MMSE)
to provide a brief global measure of cognitive functioning and
were enrolled with a score ≥ 27.
Statistical analysis
Descriptive statistics were calculated for quantitative variables
[median, interquartile range (IQR), mean, standard deviation
(SD)] and qualitative variables (percent frequencies).
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t tests were performed to determine group differences in the
UPSA-B total scores and for the two sub-domains as finances
and communication. Also effect sizes were provided by cal-
culating Cohen’s d (d), in order to show the clinical signifi-
cance of the UPSA comparisons between PLWH and HC.
We performed multivariate linear regression analyses to
explore association between UPSA-B scores and cognitive
performance, adjusting for variables showing a p value <
0.100 in univariate analysis. A 2-tailed p value of less than
0.05 was considered statistically significant. All analyses were
performed using the SPSS version 21.0 software package
(SPSS Inc., Chicago, IL).
Results
Demographic and clinical characteristics
A total of 85 Italian PLWH on cART and 23 HC were en-
rolled; their demographic and clinical characteristics are sum-
marized in Table 1. Of the 85 PLWH, 6% (n = 5) were HCV
co-infected and 28% (n = 24) with past AIDS-defining events.
Median adherence to cART was 95 (IQR 85–100) on a 0–100
VAS scale. Subjects in the two groups were matched for age
(p = 0.967) and education (p = 0.951) but significantly dif-
fered for sex (p = 0.005).
Neuropsychological evaluation
All PLWH underwent SNB. The total mean Z-score on SNB
was 0.36 (SD 0.63) with only 6 subjects (7%) who were af-
fected by HAND, all with the ANI profile according to IADL
score that was at ceiling (8/8) for all subjects.
Considering each cognitive domain separately, a higher
proportion of impairment was observed in motor abilities
(13%), followed by memory (7%), linguistic skills (5%), and
attention and executive functions (2%). Results of the neuro-
psychological performances in each cognitive domain are
shown in Table 2.
Overall, mean Zung Depression Scale score was 35 (SD
8.3), and 8.2% (n = 7) of PLWH show a probable depression.
About the health-related quality of life (SF-36), 29.4% (n =
25) and 18% (n = 16) of the PLWH showed, respectively, an
elevated negative perception of mental and physical health.
Everyday functioning evaluation
Evaluating EF by IADL, scores were at ceiling for both
PLWH and HC. However, regarding UPSA-B total score,
the mean value was significantly worse in PLWH when com-
pared with HC [mean 82.1(SD 9.3) vs 89.2 (SD 6.2);
p < 0.001] with a large effect size (d = 0.92). Exploring the
UPSA-B subtests, mean communication score significantly
Table 1 Demographic and
clinical characteristics of PLWH
group and HC
Parameters PLWH (n = 85)
N (%) or median (IQR)*
HC (n = 23)
N (%) or median (IQR)*
p
Male sex 66 (78) 11 (48) 0.005
Age (years)* 54 (48–60) 53 (47–58) 0.967
Education (years)* 13 (11–17) 13 (12–17) 0.951
Smokers 10 (12) –
Cannabis use 2 (2.4) –
Alcohol use 1 (1.2) –
Other drug use 1 (1.2) –
Transmission risk factor – –
Homosexual 35 (44)
Heterosexual 34 (43)
Injecting drug users 10 (13)
Time from HIV diagnosis (years)* 14 (4–24) – –
Time from first cART (years)* 12 (4–20) – –
Time from current cART (years)* 2 (0.9–2.7) – –
HIV-RNA < 50 copies/mL 79 (96) – –
CD4 cell count (cell/μL)* 551 (121–790) – –
CD4 nadir (cell/μL)* 100 (6–270) – –
Bold values represent statistically significant p values
N number, IQR interquartile range, PLWH people living with HIV, HC healthy control, cART combined antire-
troviral therapy
*Median and IQR reported
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differed between the two groups [mean 35.6 (SD 7.2) in
PLWH vs 41.0 (SD 5.8) in HC; p = 0.002] with a large effect
size (d = 0.83); although no significant difference was ob-
served at financial skills [mean 46.5 (SD 4.6) in PLWH vs
48.2 (SD 2.4) in HC; p = 0.096], a medium effect size was
found (d = 0.48).
In PLWH, the association between UPSA-B and cognitive
performance (total score) was analyzed by linear regression
analysis (see Table 3). At multivariate analysis, higher total
cognitive Z-score was associated with better performance at
UPSA-B total score after adjusting for education, smoking,
and adherence.
Analyzing UPSA-B subtests, at univariate analysis, better
cognitive performance (a + 1 Z-score increase in cognition is
related to a 5.54 change in UPSA-B; 95% CI 3.39/7.74,
p < 0.001) was associated with higher communication skills.
At multivariate analysis, higher total cognitive Z-score con-
firmed the association (a + 1 Z-score increase in cognition is
related to a 4.19 change in UPSA-B; 95% CI 1.80/6.59,
p < 0.001) with better communication skills after adjusting
for education, smoking, and cannabis use. Moreover, at uni-
variate analysis, better cognitive performance (a + 1 Z-score
increase in cognition is related to a 2.85 change in UPSA-B;
95% CI 1.38/4.33, p < 0.001) was correlated with higher fi-
nancial skills; at multivariate analysis, higher total cognitive
Z-score confirmed the association (a + 1 Z-score increase in
cognition is related to a 2.77 change in UPSA-B; 95% CI
1.31/4.23, p < 0.001) with higher financial skills after
adjusting for adherence.
Variables related to the severity of HIV infection (current and
nadir CD4 cell count, time from HIV diagnosis, HCV co-infec-
tion, time from ART), mood status, and health-related quality of
life were not found to be associated with EF performance mea-
sured by UPSA-B (both globally and in each subtest).
Furthermore, we investigated also the associations between
each cognitive domain and UPSA-B scores. For simplicity,
only significant associations at multivariate analyses where re-
ported. Better memory score was associated to a higher perfor-
mance at UPSA-B total (a + 1 Z-score increase in memory
domain is related to a 3.38 change in UPSA-B; 95% CI 1.41/
5.35; p = 0.001) and communication score (a + 1 Z-score in-
crease in memory domain is related to a 2.20 change in
UPSA-B; 95% CI 0.64/3.76; p = 0.006); higher language flu-
ency was associated to better performance at UPSA-B total
(a + 1 Z-score increase in language domain is related to a 2.28
change in UPSA-B; 95% CI 0.42/4.14; p = 0.012) and commu-
nication score (a + 1 Z-score increase in language domain is
related to a 1.66 change in UPSA-B; 95% CI 0.26/3.07; p =
0.021); better attention performance was associated to higher
values at UPSA-B total (a + 1 Z-score increase in attention do-
main is related to a 5.28 change in UPSA-B; 95%CI 2.93/7.62;
p < 0.001) controlling for smoking, communication skills (a + 1
Z-score increase in attention domain is related to a 2.72 change
in UPSA-B; 95% CI 0.82/4.63; p = 0.006) controlling for
smoking, and financial score (a + 1 Z-score increase in attention
domain is related to a 2.42 change in UPSA-B; 95% CI 1.24/
3.60, p < 0.001); better executive functions were associated to
higher values at UPSA-B total (a + 1 Z-score increase in exec-
utive functions domain is related to a 5.65 change in UPSA-B;
95% CI 2.49/8.80; p = 0.001) controlling for education and
smoking, communication (a + 1 Z-score increase in executive
functions domain is related to a 3.37 change in UPSA-B; 95%
CI 0.92/5.81; p = 0.008) adjusting for education and smoking,
and financial skills (a + 1 Z-score increase in executive func-
tions domain is related to a 2.33 change in UPSA-B; 95% CI
0.66/4; p = 0.007); finally, higher motor abilities were associat-
ed to higher values at UPSA-B total (a + 1 Z-score increase in
motor abilities domain is related to a 2.63 change in UPSA-B;
95% CI 0.88/4.39; p = 0.004) and financial score (a + 1 Z-score
increase in motor abilities domain is related to a 1.48 change in
UPSA-B; 95% CI 0.65/2.31; p < 0.001).
Discussion
The aim of this study was to examine EF and its association with
cognitive abilities among a sample of PLWH on cART with a
very good immunological condition, by administering a new
Table 2 Neuropsychological
performances in each cognitive
domain
Cognitive domains Mean Z-score (SD) N (%) of patients with
domain-specific impairmenta
Global Z-scoreb 0.36 (0.63) 4 (4.7%)
Memory 0.39 (1.01) 6 (7%)
Attention 0.54 (0.77) 3 (3.5%)
Executive functions 0.12 (0.57) 2 (2.4%)
Language 0.72 (1.05) 4 (4.7%)
Fine motor skills 0.05 (1.12) 11 (13%)
N number, SD standard deviation
a Based on Italian normative data
b Average of single Z-score on each domain
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multi-domain and ecological assessment tool as the UPSA-B.
The identification of a sensitive and reliable tool to assess EF is
still an unresolved need in PLWH. Indeed, it is estimated that
nearly 60% of PLWH presents problems with EF (Blackstone
et al. 2013), probably due to a combination of several factors that
are still not well understood. EF has also a central role in Frascati
criteria classification since HAND subcategories are differentiat-
ed on the basis of absence/presence and severity of both cogni-
tive and EF impairment (Antinori et al. 2007).
Our findings show that UPSA-B was much more sensitive
than IADL, the most commonly used scale, to assess EF im-
pairment in PLWH; indeed, our HIV-infected population,
composed by patients with IADL scores at ceiling, performed
significantly worse at UPSA-B when compared with HC.
IADL has shown low sensitivity in patients with no overt
dementia, partly related to the limitations of a self-reported
questionnaire (Heaton et al. 2004); at the opposite, the
UPSA-B has the advantage of considering both objective
and self-report data in the determination of patients’ functional
abilities, improving the capacity to detect also very mild EF
impairment. According to IADL, all PLWH included in our
study must be considered affected by ANI profile (Antinori
et al. 2007); however, their performance at UPSA-B suggests
that possibly some MND profile were undiagnosed.
Our results differed from other previous studies. Sheppard
found that UPSA-B was ineffective to differentiate between
HIV+ and HIV– patients (Sheppard et al. 2018), while Moore
concluded that differences in UPSA-B performance could
emerge when the HIV+ and HIV– groups are not matched
for sex and education (Moore et al. 2017). In our study, the
two groups where matched for education but not for sex; how-
ever, we found no association between sex and UPSA-B per-
formance at univariate regression analysis. Considering the
UPSA-B subtests (communication and financial skills),
PLWH showed a significantly poorer performance at commu-
nication score when compared with HC. Similarly a lower
performance at communication score was observed in another
study, despite this observation showed only a trend towards
statistically significance (Moore et al. 2017). A wider differ-
ence in our study could be explained by older age and lower
education of our population when compared with the afore-
mentioned study or by sociocultural difference in the Italian
population. Anyway, our findings hint that PLWH could
show a lower performance on tasks involving interactions
with others, as suggested by Grabyan’s study (Grabyan et al.
2018) where PLWH with HAND were impaired on emotion
identification task in association with a worse UPSA-B com-
munication score.
Table 3 Factors associated to UPSA-B total score
Univariate analysis Multivariate analysis
Mean change 95% CI p Mean change 95% CI p
Age (per 10-year increase) − 0.62 − 0.25/0.12 0.519 – – –
Education (per 1-year increase) 0.71 0.16/1.27 0.012 0.18 − 0.32/0.69 0.463
Sex (male versus female) 1.86 − 2.97/6.69 0.445 – – –
Smoking − 7.22 − 13.29/− 1.15 0.020 − 1.70 − 7.35/3.94 0.549
Cannabis use − 10.93 − 24.05/2.18 0.101 – – –
Alcohol use − 4.22 − 22.94/14.50 0.655 – – –
Other drug use 0.83 − 17.91/19.58 0.930 – – –
Years from HIV diagnosis (per 1-year increase) 0.009 − 0.09/0.11 0.869 – – –
Time from starting first cART regimen (per 1-year increase) 0.01 − 0.13/0.15 0.853 – – –
Time from starting current cART regimen (per 1-year increase) 0.01 − 0.07/0.19 0.724 – – –
Adherence (per 10% increase) 0.11 − 0.01/0.24 0.075 0.07 − 0.03/0.19 0.176
Past AIDS-defining events 1.43 − 3.05/5.90 0.527 – – –
CD4 cell count, cells/μL (per 100 cells/mL increase) 0.00 − 0.001/0.00 0.121 – – –
CD4 cell count nadir, cells/μL (per 100 cells/mL increase) 0.005 − 0.007/0.1 0.411 – – –
HIV RNA < 50 copies/mL − 8.79 − 19.74/2.15 0.114 – – –
Injecting drug users 1.98 − 4.35/8.31 0.535 – – –
Hepatitis co-infection − 5.50 − 14.2/3.1 0.211 – – –
Zung Depression Scale (per 1 point increase) −1.11 − 0.38/0.15 0.389 – – –
Mean Z-score SNB (per 1 Z-score increase) 8.28 5.63/10.9 < 0.001 7.56 4.68/10.44 < 0.001
Bold values represent statistically significant p values
CI confidence interval, cART combined antiretroviral therapy, SNB Standardized Neuropsychological Battery test
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Our findings suggested also a correlation between cogni-
tive functioning and EF performance in PLWH. Indeed, we
found an independent association between the performance at
UPSA-B total score and the global cognitive performance.
Moreover, higher performances at UPSA-B communication
and financial subtests were independently associated to better
global cognitive performance. However, we could not deeply
explore if UPSA-B might help to differentiate PLWH partic-
ipants with and without neurocognitive impairment (Sheppard
et al. 2018) because all except 6 (7%) of our participants were
cognitively unimpaired. Anyway, in countries where cART is
widely available as Europe, up to 90% of PLWH on cART are
successfully treated with stable virological suppression; in this
context, the prevalence of HAND decreased to around 20% or
less, with most patients showing the asymptomatic profile
(Ciccarelli 2020; Fabbiani et al. 2017; Garvey et al. 2011;
Milanini et al. 2016a, 2016b).
Furthermore, all cognitive domains assessed in the current
study (memory, linguistic skills, attention values, executive
functions, and motor abilities) were associated with UPSA-B
total and communication scores, while UPSA-B financial
score turned out associated with attention values, executive
functions, and motor abilities. As suggested by Sheppard
(Sheppard et al. 2018), the lack of a specific cognitive pattern
related to UPSA-B performancemight depend on the complex
nature of everyday tasks performed in the real world.
Finally, variables related to the severity of HIV infection
(current and nadir CD4 cell count, time from HIV diagnosis,
HCV co-infection, time from cART initiation), mood status,
and health-related quality of life were not associated with EF
performance measured by UPSA-B.
We acknowledge that our study has some limitations. First
of all, this is a cross-sectional study and uncontrolled biases
could occur in routine clinical practice. Thus, future longitu-
dinal studies are needed to confirm our findings and to better
clarify the UPSA-B ability in measuring EF in the HIV+ pop-
ulation. Secondly, we investigated EF in a predominately
male sample. There may be sex differences in the associations
examined, and larger sample studies are needed to analyze
them. Lastly our findings are applicable only to PLWH with
a very good viroimmunological condition and with no
neuroaids. Therefore, further investigations including more
PLWH with HAND or with worse immunological conditions
are needed, in order to identify also a good cut-point to dis-
criminate abnormal UPSA-B performance. However, a well-
controlled HIV-infected sample is more representative of the
current Italian HIV-infected population.
In conclusion, UPSA-B seemed to better discriminate EF
impairment than IADL in PLWH, and it was associated with
cognitive functions, also in the absence of symptomatic cog-
nitive impairment. On these bases, UPSA-B seems a promis-
ing tool to measure EF functioning in the context of HIV
infection, and it could be useful to avoid misdiagnosis, to
differentiate asymptomatic versus symptomatic HAND and
to detect mild EF impairments in PLWH.
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